Evidence map›Paper›PMID 41778236›Full record

ArticleCancer diagnosis & prognosis

Genetically Optimized Modular Neural Networks for Precision Lung Cancer Diagnosis: Exploratory Study of Novel Approach.

Vijay L Agrawal, Trushdeep Agrawal, Aruni Ghose, Sola Adeleke, Stergios Boussios, Rajender Singh Arora

Abstract read
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vijay L AgrawalHVPM's COET, Amravati, India.
Trushdeep AgrawalShri Vasantrao Naik Government Medical College, Yavatmal, India.
Aruni GhoseBarts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, U.K.
Sola AdelekeCancer Centre at Guy's, Guy's and St Thomas' NHS Foundation Trust, London, U.K.
Stergios BoussiosDepartment of Research and Innovation, Medway NHS Foundation Trust, Gillingham, U.K.
Rajender Singh AroraSujan Surgical Cancer Hospital & Amravati Cancer Foundation, Amravati, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Lung cancer is one of the leading causes of cancer deaths. While low-dose computed tomography (CT) screening improves survival, radiological detection is increasingly challenged by a shortage of radiologists. This study aimed to develop and evaluate a novel, precise, and computationally efficient AI-based algorithm for lung cancer diagnosis using chest CT scans. Patients and Methods: A total of 156 patient chest CT scans were utilized to form Databases I and II. We then conducted extensive feature extraction [statistics, histograms, Fast Fourier Transform (FFT), Discrete Cosine Transform (DCT), Walsh-Hadamard Transform (WHT)] and optimized classifiers [Multi Layer Perceptron (MLP), Generalized Feed Forward Neural Network (GFF-NN), Modular Neural Network (MNN), Support Vector Machine (SVM)] with genetic algorithms. Performance evaluation measures employed were classification accuracy, Mean Squared Error (MSE), Area under the ROC curve (AUC), and computational efficiency. Results: The MNN (Topology II) classifier employing FFT-based features with momentum learning achieved 100% classification accuracy during cross-validation for both Database I and Database II, consistently yielding perfect average classification accuracy across both datasets. Conclusion: The genetically optimized MNN (Topology II) classifier shows remarkable performance in lung cancer diagnosis from CT scan images. Its ability to achieve perfect classification accuracy suggests strong potential for clinical application, offering both diagnostic precision, acting as a triage, and workload reduction in healthcare settings.

Indexed as

artificial intelligencediagnosisGenetic algorithmlung cancermodular neural network

Identifiers

PMID41778236
PMCPMC12951378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.